167 related articles for article (PubMed ID: 31131369)
1. Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support.
Walther FJ; Gupta M; Lipp MM; Chan H; Krzewick J; Gordon LM; Waring AJ
Gates Open Res; 2019; 3():6. PubMed ID: 31131369
[No Abstract] [Full Text] [Related]
2. Efficacy, dose-response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs.
Walther FJ; Waring AJ; Otieno M; DiBlasi RM
Respir Res; 2022 Apr; 23(1):78. PubMed ID: 35379243
[TBL] [Abstract][Full Text] [Related]
3. Aerosol delivery of synthetic lung surfactant.
Walther FJ; Hernández-Juviel JM; Waring AJ
PeerJ; 2014; 2():e403. PubMed ID: 24918030
[TBL] [Abstract][Full Text] [Related]
4. A sulfur-free peptide mimic of surfactant protein B (B-YL) exhibits high in vitro and in vivo surface activities.
Walther FJ; Gupta M; Gordon LM; Waring AJ
Gates Open Res; 2018; 2():13. PubMed ID: 30234192
[No Abstract] [Full Text] [Related]
5. Evaluation of a Novel Dry Powder Surfactant Aerosol Delivery System for Use in Premature Infants Supported with Bubble CPAP.
DiBlasi RM; Crandall CN; Engberg RJ; Bijlani K; Ledee D; Kajimoto M; Walther FJ
Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896128
[TBL] [Abstract][Full Text] [Related]
6. Stability of an amphipathic helix-hairpin surfactant peptide in liposomes.
Waring AJ; Gupta M; Gordon LM; Fujii G; Walther FJ
Biochim Biophys Acta; 2016 Dec; 1858(12):3113-3119. PubMed ID: 27664499
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional stability of the sulfur-free surfactant protein B peptide mimic B-YL in synthetic surfactant lipids.
Walther FJ; Sharma S; Gordon LM; Waring AJ
BMC Pulm Med; 2021 Oct; 21(1):330. PubMed ID: 34686153
[TBL] [Abstract][Full Text] [Related]
8. Synthetic surfactant containing SP-B and SP-C mimics is superior to single-peptide formulations in rabbits with chemical acute lung injury.
Walther FJ; Hernández-Juviel JM; Gordon LM; Waring AJ
PeerJ; 2014; 2():e393. PubMed ID: 24883253
[TBL] [Abstract][Full Text] [Related]
9. Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome.
Walther FJ; Chan H; Smith JR; Tauber M; Waring AJ
Sci Rep; 2021 Aug; 11(1):16439. PubMed ID: 34385559
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
PeerJ; 2016; 4():e2635. PubMed ID: 27812430
[TBL] [Abstract][Full Text] [Related]
11. Activity and biophysical inhibition resistance of a novel synthetic lung surfactant containing Super-Mini-B DATK peptide.
Notter RH; Wang Z; Walther FJ
PeerJ; 2016; 4():e1528. PubMed ID: 26793419
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments.
Choi YS; Chung SH; Bae CW
Yonsei Med J; 2017 Jul; 58(4):823-828. PubMed ID: 28540997
[TBL] [Abstract][Full Text] [Related]
13. Disulphide Bridges in Surfactant Protein B Analogues Affect Their Activity in Synthetic Surfactant Preparations.
Basabe-Burgos O; Johansson J; Curstedt T
Neonatology; 2019; 115(2):134-141. PubMed ID: 30453306
[TBL] [Abstract][Full Text] [Related]
14. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
[TBL] [Abstract][Full Text] [Related]
15. Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome.
Ricci F; Catozzi C; Murgia X; Rosa B; Amidani D; Lorenzini L; Bianco F; Rivetti C; Catinella S; Villetti G; Civelli M; Pioselli B; Dani C; Salomone F
PLoS One; 2017; 12(1):e0169190. PubMed ID: 28060859
[TBL] [Abstract][Full Text] [Related]
16. Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.
Walther FJ; Waring AJ
Front Pediatr; 2022; 10():923010. PubMed ID: 35783301
[TBL] [Abstract][Full Text] [Related]
17. Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung.
Ruppert C; Kuchenbuch T; Boensch M; Schmidt S; Mathes U; Hillebrand V; Henneke I; Markart P; Reiss I; Schermuly RT; Seeger W; Günther A
Crit Care Med; 2010 Jul; 38(7):1584-91. PubMed ID: 20400897
[TBL] [Abstract][Full Text] [Related]
18. A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.
Pohlmann G; Iwatschenko P; Koch W; Windt H; Rast M; de Abreu MG; Taut FJ; De Muynck C
J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):370-9. PubMed ID: 23421901
[TBL] [Abstract][Full Text] [Related]
19. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native protein.
Walther FJ; Waring AJ; Hernández-Juviel JM; Ruchala P; Wang Z; Notter RH; Gordon LM
PeerJ; 2014; 2():e485. PubMed ID: 25083348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
